Freenome
Freenome develops blood-based cancer screening tests for healthcare providers, using a multiomics platform and machine learning to detect disease at early stages. The company’s initial product targets early colorectal cancer and advanced adenomas, with supporting software and data platforms used across its commercial, laboratory, and R&D operations. Founded in 2014 and headquartered in Brisbane, California, Freenome is privately held.
Open Positions at Freenome
1 open position
Join Freenome’s remote Platform team to build reliable, multi-tenant infrastructure powering scientific research, analytics, and business intelligence. You’ll lead high-impact platform initiatives across cloud infrastructure, Kubernetes, data lakehouse systems, and developer environments.
6 months ago